BOCCAGNI, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 3.044
EU - Europa 694
AS - Asia 479
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 4.221
Nazione #
US - Stati Uniti d'America 3.037
IT - Italia 316
CN - Cina 208
SG - Singapore 184
DE - Germania 82
FI - Finlandia 80
SE - Svezia 77
VN - Vietnam 69
FR - Francia 43
UA - Ucraina 37
GB - Regno Unito 30
IN - India 8
CA - Canada 7
GR - Grecia 7
IE - Irlanda 6
HK - Hong Kong 4
RO - Romania 4
RU - Federazione Russa 3
AU - Australia 2
ES - Italia 2
KW - Kuwait 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
CH - Svizzera 1
CL - Cile 1
IR - Iran 1
LU - Lussemburgo 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
PL - Polonia 1
SI - Slovenia 1
Totale 4.221
Città #
Chandler 369
Fairfield 340
Ann Arbor 301
Woodbridge 261
Houston 203
Ashburn 164
Jacksonville 164
Wilmington 151
Singapore 142
Cambridge 123
Seattle 123
Princeton 79
Boardman 74
Santa Clara 70
Dong Ket 69
Des Moines 65
Beijing 63
Padova 53
San Diego 39
Medford 36
Helsinki 32
Roxbury 25
Nanjing 16
New York 15
Shenyang 15
Guangzhou 12
Hebei 10
Changsha 9
Nanchang 9
Jinan 8
Rome 8
London 7
Mira 7
Norwalk 7
Dublin 6
Munich 6
Redwood City 6
Brescia 5
Los Angeles 5
Rosà 5
Shanghai 5
Balangero 4
Castel 4
Chicago 4
Florence 4
Hong Kong 4
Selvazzano Dentro 4
Tianjin 4
Washington 4
Bologna 3
Falls Church 3
Hefei 3
Jiaxing 3
Kharkiv 3
Ningbo 3
Nürnberg 3
Ogden 3
Palermo 3
Portici 3
Potenza 3
Pune 3
Thiene 3
Toronto 3
Venice 3
Verona 3
Alimena 2
Aprilia 2
Borås 2
Bronte 2
Candia 2
Catania 2
Corridonia 2
Frankfurt am Main 2
Fremont 2
Gazzo 2
Hangzhou 2
Iasi 2
Kilburn 2
Kunming 2
L’Aquila 2
Mestre 2
Modena 2
Napoli 2
Nuremberg 2
Pignone 2
Pisa 2
Rubano 2
Taizhou 2
Varese 2
Venezia 2
Zhengzhou 2
Aci Catena 1
Adliswil 1
Ancona 1
Arezzo 1
Argés 1
Berlin 1
Bharatpur 1
Brendola 1
Chenzhou 1
Totale 3.248
Nome #
Salvataggio d’organo attraverso emitrasposizione porto-cavale in trombosi porto-spleno- meseraica acuta dopo OLTx
G. 240
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience. 148
Advantages of combined technetium-99m-sestamibi scintigraphy and high-resolution ultrasonography in parathyroid localization: comparative study in 91 patients with primary hyperparathyroidism 136
Combined liver-kidney transplantation in a 15-year-old boy with alpha1-antitrypsin deficiency 129
A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation. 122
Antibiotic prophylaxis for preventing postorthotopic liver transplant tuberculosis: is there a safe alternative to isoniazid? 120
Breast complaints and risk of breast cancer. Population-based study of 2,879 self-selected women and long-term follow-up 119
Viral load in HCV RNA-positive pregnant women. 117
TRAPIANTO DI FEGATO PER EPATOCOLANGIOCARCINOMA INCIDENTALE: ESPERIENZA DI CENTRO 116
Liver transplantation for the management of hepatoblastoma 112
Comparison Between Nifedipine and Carvedilol in the Treatment of de novo Arterial Hypertension After Liver Transplantation: Preliminary Results of a Controlled Clinical Trial 102
Breast cancer risk in healthy and symptomatic women: results of a multivariate analysis. A case-control study 100
Bone metabolism in male subjects undergoing liver transplantation (OLTx) 97
USE OF ANTI-HBc POSITIVE DONORS IN LIVER TRANSPLANTATION: THE EXPERIENCE OF PADUA LIVER TRANSPLANT CENTRE 94
Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome 86
A New Allocation Model For Liver Transplantation Combining Urgency Based Prioritization With Donor-recipient Matching: A Prospective Controlled Study 84
Bone metabolism and gonad function in male patients undergoing liver transplantation: a two-year longitudinal study. 84
Nifedipine versus carvedilol in the treatment of de novo arterial hypertension after liver transplantation: Results of a controlled clinical trial. 81
Prevalence of breast cancer in women with breast complaints. Retrospective analysis in a population of symptomatic patients 80
Comparison between nifedipine and carvedilol in the treatment of “de novo” arterial hypertension after liver transplantation (LT): preliminary results of a controlled clinical trial 80
A prioritization model for liver transplantation based on a dual waiting list: a prospective controlled study
 77
Short- and long-term changes in bone mineral density following parathyroidectomy in male and female patients with primary hyperparathyroidism 76
The impact of liver disease and medical complications on quality of life and psychological distress before and after liver transplantation. 76
Usefulness of serum tumor markers CEA and CA 15-3 in patients with breast cancer. Long-term follow-up study 73
Liver transplantation for massive hepatomegaly due to polycystic liver disease: an extreme case. 73
Sensitivity of serum tumor markers CEA and CA 15-3 in breast cancer recurrences and correlation with different prognostic factors 72
Biodegradable Biliary Stents for Percutaneous Treatment of Post-liver Transplantation Refractory Benign Biliary Anastomotic Strictures 72
PERIPHERAL NK CELLS IN PATIENTS WITH HCV RECURRENCE AFTER LIVER TRANSPLANTATION DURING INTERFERON-FREE ANTIVIRAL THERAPY 71
Fine-needle aspiration cytology of adrenal masses in noncancer patients: clinicoradiologic and histologic correlations in functioning and nonfunctioning tumors 70
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation - a multicenter cohort study 69
Does sensitivity of tumor markers CEA and CA 15-3 significantly correlate with any preoperative parameters in breast cancer patients with recurrnece ? 68
Clinical value of serum markers in breast neoplasm: 5-years follow-up 66
Are breast complaints really related to breast cancer ? Results from a retrospective study in 2,561 symptomatic patients observed during a 14 years period 66
Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting 64
Development and validation of a questionnaire evaluating the impact of hepatitis B immune globulin prophylaxis on the quality of life of liver transplant recipients. 63
Long-term follow-up study in breast cancer patients using serum tumor markers CEA and CA 15-3. 60
Prevalent use of combined prophylaxis of hepatitis B after liver transplantation in Italy: results of a national survey in a large cohort 60
Multimodal approach and its impact on survival for patients with hepatocellular carcinoma 59
Calcolo dei mesi di vita guadagnati per graft utilizzato in relazione al valore del punteggio meld nel trapianto di fegato
 58
Cytokines and liver failure: modification of TNF- and IL-6 in patients with acute on chronic liver decompensation treated with Molecular Adsorbent Recycling System (MARS) 55
Management of Portal Vein (pvt) and Splacnic Veins Thrombosis (svt) In Liver Transplantation Candidates 53
Post-necrotic cirrhosis HCV-related as significant indipendent factor of mortality in an intention-to-treat analysis of liver transplantation process 50
Trapianto di fegato per epatomegalia da fegato policistico: un caso estremo. 50
Safe pregnancy after liver transplantation: Evidence from a multicenter Italian collaborative study 50
Predictive value of different prognostic factors in breast cancer recurrences: multivariate analysis using a logistic regression model. 49
PORTO-CAVAL HEMITRANSPOSITION FOR ACUTE PORTAL VEIN THROMBOSIS FOLLOWING LIVER TRANSPLANTATION FOR BUDD-CHIARI SYNDROME 48
Quantificazione e rappresentazione dell’equilibrio etico nel trapianto di fegato da cadavere e da vivente: verso processi di decisione clinica guidata da modelli matematici 47
Algorithm for the management of portal vein thrombosis: a prospective study in patients with liver cirrhosis 45
Post Transplant Lymphoproliferative Disorders In Liver Transplanted Patients: A Single Centre Experience 44
TRAPIANTO DI FEGATO DOPO EPATECTOMIA E DUODENOCEFALOPANCREASECTOMIA EN-BLOC PER EPATOBLASTOMA LOCALMENTE AVANZATO: CASE REPORT 44
Recidiva di epatite da virus C dopo trapianto di fegato. Risultati a lungo termine dell’esperienza padovana. 41
Breast complaints and age as indicators of breast diseases 41
FDG PET/MRI in the follow-up of hepatocellular carcinoma after liver transplantation 40
Thrombocytosis and recurrent hepatic outflow obstruction (Budd-Chiari syndrome) after successful thrombolysis. Case report and review of the literature. 36
SUPPORTO NUTRIZIONALE CON LA PEG NEI TRAPIANTI DI FEGATO CUORE E POLMONE D. Neri, A. Da Riva*, P. Boccagni , M. Loy, P. Feltracco, F. D’Amico, F. D’Amico, E. Gringeri, F. D’Amico, A. Vitale, F.E. D’Amico, M. Polacco, A. Bertacco, G. Noaro, U. Cillo, Padova – XXXVI Congresso Nazionale SITO (Società Italiana Trapianti d’Organo), Torino 18-20 Ottobre 2012 32
DEVELOPMENT AND VALIDATION OF AN INSTRUMENT EVALUATING THE IMPACT OF ANTI HBV IMMUNOGLOBULIN THERAPY (HBIg) ON QUALITY OF LIFE (HRQOL) IN LIVER TRANSPLANTATED (LT) PATIENTS 16
Totale 4.281
Categoria #
all - tutte 16.347
article - articoli 13.254
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.601


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020414 0 0 0 0 0 53 56 66 65 88 55 31
2020/2021636 38 38 36 45 34 38 20 63 70 63 84 107
2021/2022656 27 93 65 31 25 54 36 58 34 12 68 153
2022/2023666 104 93 20 83 106 123 1 38 60 4 31 3
2023/2024311 20 52 47 29 25 33 19 6 12 15 30 23
2024/2025400 4 89 67 51 148 41 0 0 0 0 0 0
Totale 4.281